http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-260932-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bfedd8ba4800708cecfd357707f8f67 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F251-02 |
| filingDate | 1987-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90ef7b0e555b67919a629ecb2513d551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92b1917cba3104d2a0f9abfb88500c79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_452f3d1e74398c478dea966a4764e040 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0f1b6535d54545e0a16dc7a3123f192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53ed5e1b1ae2a21fedfdde70c508818e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9455a47d886745c89efc4a7d2b802e16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_215c3fc7b7cd8bf754de4790da73e414 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed2849d16d7c95d282a9ecdf6784d854 |
| publicationDate | 1988-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DD-260932-A1 |
| titleOfInvention | METHOD FOR THE PRODUCTION OF MODIFIED CELLULOSE SURFACES WITH IMPROVED BLOOD CONTRASTING |
| abstract | The invention relates to a process for the preparation of modified cellulose surfaces having improved blood compatibility, wherein the sodium allysulfonate-based terpolymers used as modifying agents are grafted chemically covalently by a heterogeneous polymer-analogous reaction onto the regenerated cellulose molding body in the form of a flat or hollow fiber membrane. The polymer-analogous reaction is limited to the surface of the cellulosic molding, whereby the morphological basic structure of the molding remains largely intact with the aim of an unchanged separation performance. The present invention makes it possible to modify membranes of regenerated cellulose in such a way that the phenomena of leukopenia and complement activation occurring in the dialysis treatment remain markedly reduced in their extent. |
| priorityDate | 1987-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.